INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $281,227 | -26.7% | 41,540 | -1.7% | 0.08% | -25.0% |
Q2 2023 | $383,539 | +60.0% | 42,240 | +13.8% | 0.11% | +54.3% |
Q1 2023 | $239,703 | +124745.3% | 37,105 | +22.1% | 0.07% | – |
Q4 2022 | $192 | -99.9% | 30,390 | +0.5% | 0.00% | – |
Q3 2022 | $187,000 | -29.7% | 30,240 | +0.3% | 0.00% | -100.0% |
Q2 2022 | $266,000 | +19.8% | 30,140 | +14.2% | 0.00% | – |
Q1 2022 | $222,000 | +181.0% | 26,390 | +238.3% | 0.00% | – |
Q4 2021 | $79,000 | – | 7,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 275,000 | $5,341,000 | 2.77% |
Fermata Advisors, LLC | 12,830 | $249,000 | 0.11% |
DG Capital Management, LLC | 20,000 | $388,000 | 0.08% |
YorkBridge Wealth Partners, LLC | 10,369 | $201,000 | 0.05% |
Ikarian Capital, LLC | 26,632 | $517,000 | 0.04% |
Financial Advocates Investment Management | 16,667 | $324,000 | 0.02% |
Janney Montgomery Scott LLC | 99,323 | $1,929,000 | 0.01% |
Belvedere Trading LLC | 16,177 | $302,000 | 0.01% |
FNY Investment Advisers, LLC | 800 | $15,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 17,200 | $334,000 | 0.01% |